My watch list

Entecavir


Entecavir
Systematic (IUPAC) name
2-amino-9-[4-hydroxy-3-(hydroxymethyl)- 2-methylidene-cyclopentyl]-3H-purin-6-one
Identifiers
CAS number	142217-69-4
ATC code	J05AF10
PubChem	153941
DrugBank	APRD00948
Chemical data
Formula	C₁₂H₁₅N₅O₃
Mol. mass	277.279 g/mol
Pharmacokinetic data
Bioavailability	?
Protein binding	13%
Metabolism	?
Half life	128–149 hours
Excretion	Renal 62–73%
Therapeutic considerations
Licence data	EU US
Pregnancy cat.	C(US)
Legal status	℞-only(US)
Routes	Oral

Entecavir (INN) (pronounced /ɛnˈtɛkəvɪr/) is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).

Additional recommended knowledge

Don't let static charges disrupt your weighing accuracy

What is the Correct Way to Check Repeatability in Balances?

Daily Sensitivity Test

Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.

Category: Antivirals